NM_178352.3:c.122G>A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_178352.3(LCE1D):c.122G>A(p.Ser41Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000669 in 1,480,740 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178352.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000371 AC: 5AN: 134844Hom.: 1 Cov.: 22
GnomAD3 exomes AF: 0.0000775 AC: 18AN: 232138Hom.: 2 AF XY: 0.0000875 AC XY: 11AN XY: 125780
GnomAD4 exome AF: 0.0000698 AC: 94AN: 1345896Hom.: 9 Cov.: 31 AF XY: 0.0000567 AC XY: 38AN XY: 670254
GnomAD4 genome AF: 0.0000371 AC: 5AN: 134844Hom.: 1 Cov.: 22 AF XY: 0.0000304 AC XY: 2AN XY: 65788
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.122G>A (p.S41N) alteration is located in exon 2 (coding exon 1) of the LCE1D gene. This alteration results from a G to A substitution at nucleotide position 122, causing the serine (S) at amino acid position 41 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at